- Home
- MCY vs ACLX Comparison
MCY vs ACLX Comparison
Compare MCY & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCY
- ACLX
- Stock Information
- Founded
- MCY 1961
- ACLX 2015
- Country
- MCY United States
- ACLX United States
- Employees
- MCY N/A
- ACLX N/A
- Industry
- MCY Property-Casualty Insurers
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- MCY Finance
- ACLX Health Care
- Exchange
- MCY Nasdaq
- ACLX Nasdaq
- Market Cap
- MCY 4.9B
- ACLX 4.4B
- IPO Year
- MCY N/A
- ACLX 2022
- Fundamental
- Price
- MCY $92.96
- ACLX $72.77
- Analyst Decision
- MCY Strong Buy
- ACLX Strong Buy
- Analyst Count
- MCY 1
- ACLX 9
- Target Price
- MCY $100.00
- ACLX $115.50
- AVG Volume (30 Days)
- MCY 225.8K
- ACLX 912.4K
- Earning Date
- MCY 11-04-2025
- ACLX 11-05-2025
- Dividend Yield
- MCY 1.37%
- ACLX N/A
- EPS Growth
- MCY N/A
- ACLX N/A
- EPS
- MCY 7.93
- ACLX N/A
- Revenue
- MCY $5,814,768,000.00
- ACLX $35,898,000.00
- Revenue This Year
- MCY $7.13
- ACLX N/A
- Revenue Next Year
- MCY $7.60
- ACLX $220.95
- P/E Ratio
- MCY $11.71
- ACLX N/A
- Revenue Growth
- MCY 5.93
- ACLX N/A
- 52 Week Low
- MCY $44.19
- ACLX $47.86
- 52 Week High
- MCY $95.00
- ACLX $96.39
- Technical
- Relative Strength Index (RSI)
- MCY 75.27
- ACLX 29.51
- Support Level
- MCY $87.12
- ACLX $71.05
- Resistance Level
- MCY $95.00
- ACLX $92.70
- Average True Range (ATR)
- MCY 2.06
- ACLX 5.10
- MACD
- MCY 0.62
- ACLX -2.19
- Stochastic Oscillator
- MCY 80.89
- ACLX 8.52
About MCY Mercury General Corporation
Mercury General Corp is an insurance holding company. It is engaged in writing personal automobile insurance and provides related property and casualty insurance products. The Company offers the following types of automobile coverage: collision, property damage, bodily injury ("BI"), comprehensive, personal injury protection ("PIP"), underinsured and uninsured motorist, and other hazards. The Company offers the following types of homeowners coverage: dwelling, liability, personal property, and other coverages.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.